1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the ...

MORE than half a million energy customers could be moved onto smart meters in the next six months ahead of a big switch off. Letters are landing on doormats of 600,000 households who are on old ...

Over half a million households will be forced to fit a smart meter or face higher bills within six months when the BBC switches off a 40-year-old radio service. Around 600,000 energy customers on ...

MOJEC International Limited has said that it deployed no fewer than 300,000 electricity meters in 2024. The company said it has reaffirmed its position as the largest smart meter manufacturer in s ...

Roche has a big problem. With competition threatening some of its older and most lucrative biologic drugs, the Swiss pharmaceutical giant expects that, between 2023 and 2028, sales from these assets ...

If you watched this year's iPhone launch event, you could've been forgiven for thinking that the iPhone XS is the most underwhelming 'S' upgrade in the iPhone's history. Apple spent surprisingly ...

If you watched this year's iPhone launch event, you could've been forgiven for thinking that the iPhone XS is the most underwhelming 'S' upgrade in the iPhone's history. Apple spent surprisingly ...